Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hu Lei

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cell Death and Differentiation|September 24, 2025
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγHao Luo, Chujiao Zhu, Yingying Wang, et al.
Journal of Nanobiotechnology|March 22, 2026
A degradable multi-metal-chelating stealth nanoplatform for dual ferroptosis/cuproptosis-enhanced metalloimmunotherapy in leukemiaYingying Wang, Jianxiang Xu, Wenhui Bai, et al.
Immunity|June 26, 2012
The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injuryYuping Lai, Dongqing Li, Changwei Li, et al.
Acta Pharmacologica Sinica|July 23, 2020
Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathwaysMiao Yu, Zhi-Xiao Fang, Wei-Wei Wang, et al.
International Journal of Biological Sciences|April 13, 2022
IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myelomaMeng Liu, Ying Zhang, Yunzhao Wu, et al.
Redox Biology|April 30, 2025
Noscapine derivative 428 suppresses ferroptosis through targeting GPX4Youping Zhang, Haoliang Shi, Yingying Wang, et al.
Cell Death & Disease|June 29, 2026
TRMT1-mediated tRNA m<sup>2</sup><sub>2</sub>G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinomaJiaqi Li, Bo Jing, Yingying Wang, et al.
Acta Pharmaceutica Sinica. B|January 14, 2025
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cellsYingying Wang, Youping Zhang, Hao Luo, et al.
Nature Communications|January 5, 2021
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemiaHu Lei, Han-Zhang Xu, Hui-Zhuang Shan, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cell Death and Differentiation|September 24, 2025
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγHao Luo, Chujiao Zhu, Yingying Wang, et al.
Journal of Nanobiotechnology|March 22, 2026
A degradable multi-metal-chelating stealth nanoplatform for dual ferroptosis/cuproptosis-enhanced metalloimmunotherapy in leukemiaYingying Wang, Jianxiang Xu, Wenhui Bai, et al.
Immunity|June 26, 2012
The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injuryYuping Lai, Dongqing Li, Changwei Li, et al.
Acta Pharmacologica Sinica|July 23, 2020
Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathwaysMiao Yu, Zhi-Xiao Fang, Wei-Wei Wang, et al.
International Journal of Biological Sciences|April 13, 2022
IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myelomaMeng Liu, Ying Zhang, Yunzhao Wu, et al.
Redox Biology|April 30, 2025
Noscapine derivative 428 suppresses ferroptosis through targeting GPX4Youping Zhang, Haoliang Shi, Yingying Wang, et al.
Cell Death & Disease|June 29, 2026
TRMT1-mediated tRNA m<sup>2</sup><sub>2</sub>G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinomaJiaqi Li, Bo Jing, Yingying Wang, et al.
Acta Pharmaceutica Sinica. B|January 14, 2025
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cellsYingying Wang, Youping Zhang, Hao Luo, et al.
Nature Communications|January 5, 2021
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemiaHu Lei, Han-Zhang Xu, Hui-Zhuang Shan, et al.
Pageof 7